Gene regulatory elements of the cardiac conduction system

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Epigenetics

Background:

• Cardiac conduction relies on electrical impulse generation and propagation.
• Dysfunction in the cardiac conduction system is linked to arrhythmias and sudden cardiac death.
• Genetic factors, including ion channel and transcription factor genes, are crucial for conduction system function.

Purpose of the Study:

• To investigate the role of genetic variations in non-coding DNA within the cardiac conduction system.
• To explore how sequence variants in regulatory elements influence gene expression and cardiac function.
• To highlight the impact of non-coding variants on arrhythmogenic disorders.

Main Methods:

• Genome-wide association studies (GWAS) to identify trait-associated variants.
• Functional studies, including reporter gene assays, to assess enhancer activity.
• Chromatin immunoprecipitation sequencing (ChIP-seq) and chromatin conformation capture technologies to identify regulatory DNA.
• Analysis of sequence conservation and epigenetic marks.

Main Results:

• A significant portion of disease-associated variants reside in non-coding regions with regulatory potential.
• Studies on SCN5A/SCN10A and TBX5 enhancers demonstrate the functional impact of single-nucleotide polymorphisms (SNPs).
• Risk variants were shown to abrogate enhancer function, affecting cardiac gene expression and highlighting their role in cardiac conduction.

Conclusions:

• Variations in gene regulatory elements significantly contribute to cardiac conduction system function and dysfunction.
• Epigenetic marks and sequence conservation aid in identifying functional regulatory DNA.
• Advancements in genome modification technologies will further elucidate the role of regulatory DNA in cardiac disorders.